IBBvsHTECETF Comparison
VS
ETF 2
HTEC
Robo Global Healthcare Technology and Innovation ETF
This fund is part of
Multiple Trends
-1.93%
iShares Biotechnology ETF (IBB) belongs to the US Health Care segment. Robo Global Healthcare Technology and Innovation ETF (HTEC) is part of the Multiple Trends segment. IBB's top 3 sector exposures are Healthcare, Non-Corporate and Non-Energy Materials. In contrast, HTEC's top sector exposures are Healthcare, Consumer Non-Cyclicals and Business Services. IBB is less expensive with a Total Expense Ratio (TER) of 0.44%, versus 0.8% for HTEC. IBB is up 20.17% year-to-date (YTD) with +$332M in YTD flows. HTEC performs worse with 17.52% YTD performance, and +$11M in YTD flows. Run a side-by-side ETF comparison of IBB and HTEC below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
IBB vs HTEC performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 09/10/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | IBB HTEC | +1.32%+1.04% | +22.15%+20.40% | +20.17%+17.52% | +44.46%+36.17% | +60.12%+54.82% | +18.70%-14.85% |
| Flows | IBB HTEC | +$288M-$4K | +$826M+$7M | +$332M+$11M | +$1.80B+$10M | -$589M-$33M | -$1.26B-$91M |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | IBB HTEC | +24.50%+22.63% | +21.85%+21.16% | +21.07%+20.94% | +22.48%+24.23% |
| Max drawdown | IBB HTEC | -6.57%-4.47% | -9.61%-16.84% | -24.82%-22.68% | -38.96%-55.34% |
| Max drawdown duration | IBB HTEC | 22d14d | 151d160d | 377d237d | 1523d1826d |
Trading data
IBB | HTEC | |
Last sale 9/11/2026 at 5:05 PM | $203.30 | $40.73 |
| Previous close 09/10/2026 | $202.64 | $40.42 |
| Consolidated volume 09/10/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of August 31, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
IBB | HTEC | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 9/11/2026 at 5:05 PM
Live
Closed
IBB | HTEC | |
|---|---|---|
| Last price | $203.30 | $40.73 |
| 1D performance | +0.33% | +0.77% |
| AuM | $10.30 B | $74.99 M |
| E/R | 0.44% | 0.8% |
Characteristics
IBB | HTEC | |
|---|---|---|
| Management strategy | Passive | Passive |
| Provider | iShares | ROBO Global ETFs |
| Benchmark | ICE Biotechnology Index | ROBO Global Healthcare Technology and Innovation |
| N° of holdings | 240 | 63 |
| Asset class | Equities | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | February 5, 2001 | June 25, 2019 |
| ESG | No | Yes |
Advertisement
Exposure
Countries
IBB
USA
86.04%
Other
13.96%
HTEC
USA
75.7%
Other
24.3%
Sectors
IBB
Healthcare
99.83%
Other
0.17%
HTEC
Healthcare
94.38%
Other
5.62%
Advertisement
Diversification
IBB
Total weight of top 15 holdings out of 15
54.48%
HTEC
Total weight of top 15 holdings out of 15
31.72%
Top 15 holdings
Data as of July 31, 2026
IBB
Amgen, Inc.
8.42%
Vertex Pharmaceuticals, Inc.
7.87%
Gilead Sciences, Inc.
7.14%
Regeneron Pharmaceuticals, Inc.
5.84%
argenx SE
3.55%
Natera, Inc.
2.88%
Revolution Medicines, Inc.
2.87%
Illumina, Inc.
2.42%
Biogen, Inc.
2.38%
Alnylam Pharmaceuticals, Inc.
2.14%
BeOne Medicines Ltd.
2.01%
Incyte Corp.
1.91%
Insmed, Inc.
1.71%
United Therapeutics Corp.
1.69%
Moderna, Inc.
1.65%
HTEC
CareDx, Inc.
2.68%
Guardant Health, Inc.
2.32%
Natera, Inc.
2.23%
Twist Bioscience Corp.
2.23%
Thermo Fisher Scientific, Inc.
2.18%
Medpace Holdings, Inc.
2.12%
Adaptive Biotechnologies Corp.
2.11%
IQVIA Holdings, Inc.
2.10%
Illumina, Inc.
2.09%
Arrowhead Pharmaceuticals, Inc.
2.08%
Regeneron Pharmaceuticals, Inc.
1.97%
Glaukos Corp.
1.92%
Vertex Pharmaceuticals, Inc.
1.91%
Stryker Corp.
1.91%
LivaNova Plc
1.87%
Frequently asked questions about IBB and HTEC
How have the IBB and HTEC ETFs performed in 2026?
As of September 10, 2026, IBB is up 20.17% year-to-date (YTD), while HTEC has returned 17.52%. That puts IBB better performer ahead so far this year.
Which ETF is attracting more investor money: IBB or HTEC?
Year-to-date, the IBB ETF saw +$332M in flows, compared to +$11M for HTEC.
Which ETF is more volatile: IBB or HTEC?
Over the past year, IBB had a volatility of 21.85%, while HTEC experienced 21.16%.
Which ETF is bigger: IBB or HTEC?
As of September 10, 2026, IBB holds $10.30 B in assets under management (AUM), while HTEC manages $74.99 M.
What sectors do the IBB and HTEC ETFs invest in?
IBB leans toward sectors like Healthcare. Meanwhile, HTEC focuses on Healthcare.
What are the top holdings of the IBB ETF and HTEC ETF?
IBB top holdings include Amgen, Inc., Vertex Pharmaceuticals, Inc. and Gilead Sciences, Inc.. HTEC holds in its top three: CareDx, Inc., Guardant Health, Inc. and Natera, Inc..
Which ETF is more diversified: IBB or HTEC?
IBB holds 241 securities with 54.48% of its assets in the top 15. HTEC has 63 securities and a top 15 weight of 31.72%.
Advertisement
Latest news about IBB & HTEC
Small-Cap Biotech ETFs: High-Risk, High-Reward Opportunities
September 18, 2025
IBB
Are Biotechnology ETFs In the Midst of a Comeback?
August 20, 2025
IBB
Investing in the Aging Population: A Look at Bonds and Pharma ETFs
March 27, 2023
IBB
Health is Wealth: A look at the Healthcare Sector
January 24, 2023
IBB
Advertisement
Biggest potential ETF theme - Innovation
October 13, 2022
HTEC
Biggest potential ETF theme - Innovation
October 13, 2022
HTEC
Biotech ETFs – Investing in Health Innovation
July 21, 2022
IBB
Advertisement
